WHO Pharmaceuticals Newsletter: No.1, 2024

A case study on the ecosystem for local production of pharmaceuticals, vaccines, and biologicals: the Nigeria context

Price setting and regulation in health services

Good urban governance for health and well-being: a systematic review of barriers, facilitators and indicators

All for Health, Health for All: investment case 2025-2028

Paediatric drug optimization for tuberculosis: meeting report, October 2023

Paediatric drug optimization for COVID-19: meeting report, 6 September 2022

Guidance on implementation of a quality system in blood establishments

Strategic framework for collaboration on antimicrobial resistance – together for One Health

Strategies to facilitate sharing of technology and knowledge through WHO COVID-19 Technology Access Pool

WHO guideline on self-care Interventions for health and well-being, 2022 revision: executive summary

Towards investigation, development and introduction of cefiderocol in children: product brief

Paediatric drug optimization for neglected tropical diseases: meeting report, September 2023

Rehabilitation indicator menu: a tool accompanying the Framework for Rehabilitation Monitoring and Evaluation (FRAME), Edition 2

WHO global technical consultation on public health and social measures during health emergencies: report of the second meeting, Geneva, Switzerland, 21-23 November 2023

Global perspectives on assistive technology: proceedings of the GReAT Consultation 2019, World Health Organization, Geneva, Switzerland, 22–23 August 2019. Volume 2

Workload indicators of staffing need: user’s manual: Second edition, Edition 2

Risk communication and community engagement readiness and response toolkit: dengue fever

WHO country stories: delivering for all

Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents